Association, and the Cephalon Corporation. The local and international organizing committees extend their most sincere thanks to these organizations for their support.
The meeting was attended by approximately 502 registrants, representing 27 nations. The general consensus of those attending was that the scientific quality of the material presented was outstanding. Intriguing new work on the application of tissue transplantation in animal models of learning and memory disorders, pain, depression, and Huntington's disease, for example, was presented. Other topics in which new findings were presented included methods of functional assessment, development of cell lines and the use of alternate cell types for transplantation, new transplantation methods including encapsulation and the use of support matrices, and the use of neuronal transplants to examine the function and development of neuronal circuits. Although clinical application remains controversial, there continue to be promising indications of positive clinical effects. The large number of abstracts related to Parldnson's disease testifies both to the continued interest and to promising recent developments in this area. New technologies, ranging from localized administration of growth factors and drugs to the intracerebral implantation of alternative tissues, genetically altered cell lines, immunology, and artificial growth-promoting substrates have helped to expand the boundaries of research in neural tissue transplantation.
Highlights from the meeting included:
The use of cell lines for transplantation, including genetically modified cells and immortalized cell lines. The two approaches for generating transplantable cells differ markedly; one approach seeks to introduce desirable characteristics (e.g., eDNA encoding enzymes or growth factors) into cells which already possess the ability to reproduce in culture. The second approach seeks to introduce the ability to replicate indefinitely (i.e., immortalization), into cells which already possess all of the other desired functional properties. For example, in the case of Parkinson's disease models, the two approaches are exemplified by studies which seek to produce immortalized mesencephalic neurons or adrenal chromaffin cells or, conversely, to introduce tyrosine hydroxylase eDNA into either primary cells (such as astrocytes) or into cell lines, so that they produce either dopamine or L-DOPA. Several papers reported on the development of immortalized cell lines, including mesencephalic cells or Schwann cells, or on the development of genetically modified astrocytes or fibroblasts which produce NGF.
Methods for obtaining improved survival of intracerebrally grafted chromaffin cells, including co-transplantation with peripheral nerve and pre-transected peripheral nerve, infusions of nerve growth factor, the use of preparations of purified chromaffin cells for transplantation, and techniques for assisting transport of nerve growth factor through the blood-brain barrier were presented. This is currently a major focus of research in adrenal medulla transplantation in both animal models and clinical studies.
Advances in clinical studies included longer follow-up periods for earlier patient groups, improved experimental design and assessment methods, and progressive improvements in transplantation techniques. Several studies reported on long term clinical studies of fetal tissue transplantation, with follow-up periods in excess of two years. Some reports indicated progressive improvement continuing for more than one year after transplantation. Donor tissue age and transplantation site continue to be major areas of controversy. Coordination of studies through registries and standardized assessment programs, and the possibility of inclusion of control procedures or comparison groups, also continued to be major topics of discussion.
Parkinson's disease continues to be a major area of emphasis for studies of neural transplantation, as evidenced by the substantial number of papers on this topic. For example, approximately 40 of the 95 extended abstracts in this volume are directly related to Parkinson's disease. On the other hand, there was a considerable number of exciting new developments in other models of CNS injury and disorders, and in application of transplantation for basic studies of development and neuronal circuitry. The extended abstracts include papers on models of pain, depression, epilepsy, Huntington's disease, cognitive dysfunction, spinal cord injury, hypoxia/ischemia, activitybased anorexia, and cortical injury. In the case of pain models, the animal studies have led to promising preliminary results in a clinical trial on the application of adrenal medulla transplantation in cancer patients with chronic pain.
The meeting proceedings will be communicated through scientific journals according to the following scheme: (i) Abstracts of essentially all presented papers were published in a special issue of Restorative Neurology and Neuroscience (Volume 4 Number 3, July 1992). (ii)
The extended abstracts of selected papers, submitted on the initiative of the presenters, are published in the current issue. (iii) Five journals (Experimental Neurology, Restorative Neurology and Neuroscience, Regional Immunology, Cell Transplantation, and Journal of Neural Transplantation and Plasticity) have agreed to devote special issues to the publication of peerreviewed papers on the original data presented at the meeting, at the participants' initiative, provided sufficient papers are received. (iv) The Journal of Neural Transplantation and Plasticity (JNTP) will punish a report on the meeting in 1993. When the list of meeting-related citations is complete, it will be sent to anyone sending a self-addressed envelope to the JNTP editorial office.
